enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Mantle cell lymphoma - Wikipedia

   en.wikipedia.org/wiki/Mantle_cell_lymphoma

   Mantle cell lymphoma (MCL) is a type of non-Hodgkin's lymphoma, comprising about 6% of cases. [ 1 ] [ 2 ] It is named for the mantle zone of the lymph nodes where it develops. [ 3 ] [ 4 ] The term 'mantle cell lymphoma' was first adopted by Raffeld and Jaffe in 1991.

3. Monoclonal B-cell lymphocytosis - Wikipedia

   en.wikipedia.org/wiki/Monoclonal_B-cell_lymphocy...

   Mantle cell lymphoma: The monoclonal B-cells in this aggressive lymphoma are CD5+ in most cases, CD10−, CD23−, CD43+, CD103−, complete Ig+, and express cyclin D1; these cells have translocations between chromosomes 11 and 14 in >95% of cases and in many cases overexpress the SOX11 transcription factor gene. [2]

4. Aggressive lymphoma - Wikipedia

   en.wikipedia.org/wiki/Aggressive_lymphoma

   Aggressive lymphoma, also known as high-grade lymphoma, is a group of fast growing non-Hodgkin lymphoma. [1]There are several subtypes of aggressive lymphoma. These include AIDS-associated lymphoma, angioimmunoblastic lymphoma, Burkitt lymphoma, central nervous system (CNS) lymphoma, diffuse large B-cell lymphoma (DLBCL), mantle cell lymphoma (MCL) and peripheral T-cell lymphoma. [1]

5. Non-Hodgkin lymphoma - Wikipedia

   en.wikipedia.org/wiki/Non-Hodgkin_lymphoma

   The most common chemotherapy used for B-cell non-Hodgkin lymphoma is R-CHOP, which is a regimen of four drugs (cyclophosphamide, doxorubicin, vincristine, and prednisone) plus rituximab. [ 33 ] R-CHP with polatuzumab vedotin , an antibody-drug conjugate, was included as a category 1 preferred regimen for first-line DLBCL by the National ...

6. Lymphoma - Wikipedia

   en.wikipedia.org/wiki/Lymphoma

   Four chimeric antigen receptor T cell therapies are FDA-approved for non-Hodgkin lymphoma, including lisocabtagene maraleucel (for relapsed or refractory large B-cell lymphoma with two failed systemic treatments), axicabtagene ciloleucel, tisagenlecleucel (for large B-cell lymphoma), and brexucabtagene autoleucel (for mantle cell lymphoma ...

7. Chronic lymphocytic leukemia - Wikipedia

   en.wikipedia.org/wiki/Chronic_lymphocytic_leukemia

   Hematologic disorders that may resemble CLL in their clinical presentation, behavior, and microscopic appearance include mantle cell lymphoma, marginal zone lymphoma, B cell prolymphocytic leukemia, and lymphoplasmacytic lymphoma. B cell prolymphocytic leukemia, a related, but more aggressive disorder, has cells with similar phenotype, but are ...

8. Cancer survival rates - Wikipedia

   en.wikipedia.org/wiki/Cancer_survival_rates

   Small cell lung cancer has a five-year survival rate of 4% according to Cancer Centers of America's Website. [5] The American Cancer Society reports 5-year relative survival rates of over 70% for women with stage 0-III breast cancer with a 5-year relative survival rate close to 100% for women with stage 0 or stage I breast cancer.

9. Splenic marginal zone lymphoma - Wikipedia

   en.wikipedia.org/wiki/Splenic_marginal_zone_lymphoma

   Splenic marginal zone lymphoma (SMZL) is a type of marginal zone lymphoma, a cancer made up of B-cells that replace the normal architecture of the white pulp of the spleen. The neoplastic cells are both small lymphocytes and larger, transformed lymphoblasts , and they invade the mantle zone of splenic follicles and erode the marginal zone ...